April 22, 2013

Hexyon/Hexacima 6-in-1 Pediatric Vaccine Approved in Europe

Hexyon/Hexacima is the only fully liquid, ready-to-use, 6-in-1 pediatric vaccine

 

Hexyon/Hexacima 6-in-1 Pediatric Vaccine Approved in Europe
Hexyon/Hexacima is the only fully liquid, ready-to-use, 6-in-1 pediatric vaccine

Lyon, France – April 22, 2013 – Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and NYSE: SNY), announced today that the European Commission approved Sanofi Pasteur’s 6-in- 1 pediatric vaccine HexyonTM/Hexacima® (DTaP-IPV-Hib-HepB vaccine) for primary and booster vaccination of infants from six weeks of age.